Introduction of low dose transdermal buprenorphine -- did it influence use of potentially addictive drugs in chronic non-malignant pain patients?

@article{Skurtveit2009IntroductionOL,
  title={Introduction of low dose transdermal buprenorphine -- did it influence use of potentially addictive drugs in chronic non-malignant pain patients?},
  author={Svetlana Skurtveit and Kari Furu and Stein Kaasa and Petter Christian Borchgrevink},
  journal={European journal of pain},
  year={2009},
  volume={13 9},
  pages={949-53}
}
The aim was to study the introduction of the new low dose transdermal buprenorphine (LD-TD-BUP) in Norway, particularly with regard to former use and co-medication with other potentially addictive drugs. The nationwide Norwegian Prescription Database contains information on all prescription drugs dispensed to individual non-institutionalised patients, and we may follow all individuals who received LD-TD-BUP (Norspan) after marketing on the Norwegian market on 15/11/05. We studied all… CONTINUE READING